255 related articles for article (PubMed ID: 26052977)
1. Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.
Maldonado F; Duan F; Raghunath SM; Rajagopalan S; Karwoski RA; Garg K; Greco E; Nath H; Robb RA; Bartholmai BJ; Peikert T
Am J Respir Crit Care Med; 2015 Sep; 192(6):737-44. PubMed ID: 26052977
[TBL] [Abstract][Full Text] [Related]
2. Software-based risk stratification of pulmonary adenocarcinomas manifesting as pure ground glass nodules on computed tomography.
Nemec U; Heidinger BH; Anderson KR; Westmore MS; VanderLaan PA; Bankier AA
Eur Radiol; 2018 Jan; 28(1):235-242. PubMed ID: 28710575
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography.
Raghunath S; Maldonado F; Rajagopalan S; Karwoski RA; DePew ZS; Bartholmai BJ; Peikert T; Robb RA
J Thorac Oncol; 2014 Nov; 9(11):1698-703. PubMed ID: 25170645
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive Quantitative Imaging-based Biomarkers and Lung Cancer Screening.
Schabath MB; Gillies RJ
Am J Respir Crit Care Med; 2015 Sep; 192(6):654-6. PubMed ID: 26371810
[No Abstract] [Full Text] [Related]
5. Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions.
Clay R; Rajagopalan S; Karwoski R; Maldonado F; Peikert T; Bartholmai B
Transl Lung Cancer Res; 2018 Jun; 7(3):313-326. PubMed ID: 30050769
[TBL] [Abstract][Full Text] [Related]
6. Computed Tomography-Based Score Indicative of Lung Cancer Aggression (SILA) Predicts the Degree of Histologic Tissue Invasion and Patient Survival in Lung Adenocarcinoma Spectrum.
Varghese C; Rajagopalan S; Karwoski RA; Bartholmai BJ; Maldonado F; Boland JM; Peikert T
J Thorac Oncol; 2019 Aug; 14(8):1419-1429. PubMed ID: 31063863
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)--a pilot study.
Maldonado F; Boland JM; Raghunath S; Aubry MC; Bartholmai BJ; Deandrade M; Hartman TE; Karwoski RA; Rajagopalan S; Sykes AM; Yang P; Yi ES; Robb RA; Peikert T
J Thorac Oncol; 2013 Apr; 8(4):452-60. PubMed ID: 23486265
[TBL] [Abstract][Full Text] [Related]
8. Computer-Aided Nodule Assessment and Risk Yield Risk Management of Adenocarcinoma: The Future of Imaging?
Foley F; Rajagopalan S; Raghunath SM; Boland JM; Karwoski RA; Maldonado F; Bartholmai BJ; Peikert T
Semin Thorac Cardiovasc Surg; 2016; 28(1):120-6. PubMed ID: 27568149
[TBL] [Abstract][Full Text] [Related]
9. Assessing the inter-observer variability of Computer-Aided Nodule Assessment and Risk Yield (CANARY) to characterize lung adenocarcinomas.
Nakajima EC; Frankland MP; Johnson TF; Antic SL; Chen H; Chen SC; Karwoski RA; Walker R; Landman BA; Clay RD; Bartholmai BJ; Rajagopalan S; Peikert T; Massion PP; Maldonado F
PLoS One; 2018; 13(6):e0198118. PubMed ID: 29856852
[TBL] [Abstract][Full Text] [Related]
10. Computer-Aided Nodule Assessment and Risk Yield (CANARY) may facilitate non-invasive prediction of EGFR mutation status in lung adenocarcinomas.
Clay R; Kipp BR; Jenkins S; Karwoski RA; Maldonado F; Rajagopalan S; Voss JS; Bartholmai BJ; Aubry MC; Peikert T
Sci Rep; 2017 Dec; 7(1):17620. PubMed ID: 29247171
[TBL] [Abstract][Full Text] [Related]
11. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
[TBL] [Abstract][Full Text] [Related]
13. Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
Li Z; Ye B; Bao M; Xu B; Chen Q; Liu S; Han Y; Peng M; Lin Z; Li J; Zhu W; Lin Q; Xiong L
PLoS One; 2015; 10(9):e0136616. PubMed ID: 26339917
[TBL] [Abstract][Full Text] [Related]
14. An integrated segmentation and shape-based classification scheme for distinguishing adenocarcinomas from granulomas on lung CT.
Alilou M; Beig N; Orooji M; Rajiah P; Velcheti V; Rakshit S; Reddy N; Yang M; Jacono F; Gilkeson RC; Linden P; Madabhushi A
Med Phys; 2017 Jul; 44(7):3556-3569. PubMed ID: 28295386
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
16. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.
Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995
[TBL] [Abstract][Full Text] [Related]
17. Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.
Schabath MB; Massion PP; Thompson ZJ; Eschrich SA; Balagurunathan Y; Goldof D; Aberle DR; Gillies RJ
PLoS One; 2016; 11(8):e0159880. PubMed ID: 27509046
[TBL] [Abstract][Full Text] [Related]
18. Subcentimeter lung nodules stable for 2 years at LDCT: long-term follow-up using volumetry.
Shin KE; Lee KS; Yi CA; Chung MJ; Shin MH; Choi YH
Respirology; 2014 Aug; 19(6):921-8. PubMed ID: 24934105
[TBL] [Abstract][Full Text] [Related]
19. The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CT.
Sonavane SK; Pinsky P; Watts J; Gierada DS; Munden R; Singh SP; Nath H
Eur Radiol; 2017 Dec; 27(12):5113-5118. PubMed ID: 28616728
[TBL] [Abstract][Full Text] [Related]
20. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
